158 related articles for article (PubMed ID: 27026197)
21.
Ferreira CA; Ehlerding EB; Rosenkrans ZT; Jiang D; Sun T; Aluicio-Sarduy E; Engle JW; Ni D; Cai W
Mol Pharm; 2020 May; 17(5):1697-1705. PubMed ID: 32202792
[TBL] [Abstract][Full Text] [Related]
22. Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer.
Liu Z; Li ZB; Cao Q; Liu S; Wang F; Chen X
J Nucl Med; 2009 Jul; 50(7):1168-77. PubMed ID: 19525469
[TBL] [Abstract][Full Text] [Related]
23. Development of [
Otaru S; Paulus A; Imlimthan S; Kuurne I; Virtanen H; Liljenbäck H; Tolvanen T; Auchynnikava T; Roivainen A; Helariutta K; Sarparanta M; Airaksinen AJ
Bioconjug Chem; 2022 Jul; 33(7):1393-1404. PubMed ID: 35709482
[TBL] [Abstract][Full Text] [Related]
24. GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog.
Schuhmacher J; Zhang H; Doll J; Mäcke HR; Matys R; Hauser H; Henze M; Haberkorn U; Eisenhut M
J Nucl Med; 2005 Apr; 46(4):691-9. PubMed ID: 15809493
[TBL] [Abstract][Full Text] [Related]
25. Preclinical evaluation of ⁸⁹Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model.
Sugyo A; Tsuji AB; Sudo H; Nagatsu K; Koizumi M; Ukai Y; Kurosawa G; Zhang MR; Kurosawa Y; Saga T
Nucl Med Commun; 2015 Mar; 36(3):286-94. PubMed ID: 25460304
[TBL] [Abstract][Full Text] [Related]
26. Pretargeted PET of Osteodestructive Lesions in Dogs.
Maitz CA; Delaney S; Cook BE; Genady AR; Hoerres R; Kuchuk M; Makris G; Valliant JF; Sadeghi S; Lewis JS; Hennkens HM; Bryan JN; Zeglis BM
Mol Pharm; 2022 Sep; 19(9):3153-3162. PubMed ID: 35635337
[TBL] [Abstract][Full Text] [Related]
27. Matching the decay half-life with the biological half-life: ImmunoPET imaging with (44)Sc-labeled cetuximab Fab fragment.
Chakravarty R; Goel S; Valdovinos HF; Hernandez R; Hong H; Nickles RJ; Cai W
Bioconjug Chem; 2014 Dec; 25(12):2197-204. PubMed ID: 25389697
[TBL] [Abstract][Full Text] [Related]
28. The Use of PET Imaging for Prognostic Integrin α
Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
[TBL] [Abstract][Full Text] [Related]
29. Feasibility study of the Fab fragment of a monoclonal antibody against tissue factor as a diagnostic tool.
Tsumura R; Sato R; Furuya F; Koga Y; Yamamoto Y; Fujiwara Y; Yasunaga M; Matsumura Y
Int J Oncol; 2015 Dec; 47(6):2107-14. PubMed ID: 26497165
[TBL] [Abstract][Full Text] [Related]
30. (18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry.
Meyer JP; Houghton JL; Kozlowski P; Abdel-Atti D; Reiner T; Pillarsetty NV; Scholz WW; Zeglis BM; Lewis JS
Bioconjug Chem; 2016 Feb; 27(2):298-301. PubMed ID: 26479967
[TBL] [Abstract][Full Text] [Related]
31. Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic cancer.
Sugyo A; Aung W; Tsuji AB; Sudo H; Takashima H; Yasunaga M; Matsumura Y; Saga T; Higashi T
Oncol Rep; 2019 Apr; 41(4):2371-2378. PubMed ID: 30816521
[TBL] [Abstract][Full Text] [Related]
32. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule.
Su X; Cheng K; Liu Y; Hu X; Meng S; Cheng Z
Amino Acids; 2015 Jul; 47(7):1409-19. PubMed ID: 25854877
[TBL] [Abstract][Full Text] [Related]
33. Development of positron emission tomography imaging by 64Cu-labeled Fab for detecting ERC/mesothelin in a mesothelioma mouse model.
Yoshida C; Sogawa C; Tsuji AB; Sudo H; Sugyo A; Uehara T; Hino O; Yoshii Y; Fujibayashi Y; Fukumura T; Koizumi M; Arano Y; Saga T
Nucl Med Commun; 2010 May; 31(5):380-8. PubMed ID: 20072072
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody.
Zhang Y; Hong H; Engle JW; Yang Y; Theuer CP; Barnhart TE; Cai W
Mol Pharm; 2012 Mar; 9(3):645-53. PubMed ID: 22292418
[TBL] [Abstract][Full Text] [Related]
35. ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.
Sun H; England CG; Hernandez R; Graves SA; Majewski RL; Kamkaew A; Jiang D; Barnhart TE; Yang Y; Cai W
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2169-2179. PubMed ID: 27342417
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of prognostic integrin α2β1 PET tracer and concurrent targeting delivery using focused ultrasound for brain glioma detection.
Chung YH; Hsu PH; Huang CW; Hsieh WC; Huang FT; Chang WC; Chiu H; Hsu ST; Yen TC
Mol Pharm; 2014 Nov; 11(11):3904-14. PubMed ID: 25153169
[TBL] [Abstract][Full Text] [Related]
37. ImmunoPET Imaging of CD47 with VHH-Derived Tracers in Pancreatic Cancers.
Liang C; Huang W; Zhang Y; Zhang D; An S; Wu Q; Zhao H; Wang C; Huang G; Wei W; Liu J
Mol Pharm; 2023 Aug; 20(8):4184-4195. PubMed ID: 37403817
[TBL] [Abstract][Full Text] [Related]
38. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
[TBL] [Abstract][Full Text] [Related]
39. Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model.
Hausner SH; Abbey CK; Bold RJ; Gagnon MK; Marik J; Marshall JF; Stanecki CE; Sutcliffe JL
Cancer Res; 2009 Jul; 69(14):5843-50. PubMed ID: 19549907
[TBL] [Abstract][Full Text] [Related]
40. An orthotopic model of pancreatic somatostatin receptor (SSTR)-positive tumors allows bimodal imaging studies using 3T MRI and animal PET-based molecular imaging of SSTR expression.
Stelter L; Amthauer H; Rexin A; Pinkernelle J; Schulz P; Michel R; Denecke T; Stiepani H; Hamm B; Wiedenmann B; Scholz A
Neuroendocrinology; 2008; 87(4):233-42. PubMed ID: 18025811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
